[Skip to content]

European Parkinson's Disease Association
Search our Site

Research papers


Quality of life (QoL) research papers

  • Stopwatch Appetitive motivational deficits in individuals with Parkinson's DiseaseThe current study tested the hypothesis that patients with Parkinson's disease would show a deficit in appetitive motivational arousal. Patients with Parkinson's disease and age-matched healthy controls completed a visual discrimination task in which control and appetitive food images (incidental to the task) were presented in the background. 15 August 2011
  • Quality of Life Friends Couple walking in woods Balance and falls in Parkinson's disease: A meta-analysis of the effect of exercise and motor trainingThis systematic review with meta-analysis aimed to determine the effects of exercise and motor training on the performance of balance-related activities and falls in people with Parkinson's disease. 01 August 2011
  • Quality of Life Friends Couple walking in woods How People Living with Parkinson's Disease in Four European Countries View Occupational TherapyIn this sample, differences in OT services for people with Parkinson's were reported. Where OT services were received, it was seen as an important intervention. Further studies with a larger sample and involving more countries are needed to verify and build-on these findings. 28 July 2011
  • Quality of Life Friends Couple walking in woods Does vigorous exercise have a neuroprotective effect in Parkinson disease?Among seniors in general, exercise or physical fitness has not only been associated with better cognitive scores, but midlife exercise significantly reduces the later risk of both dementia and mild cognitive impairment. 19 July 2011
  • conundrum and confusion Depression and anxiety related subtypes in Parkinson's diseaseDepression in PD may manifest in two clinical phenotypes, one 'anxiousdepressed' and the other 'depressed'. However, a further large proportion of patients can have relatively isolated anxiety. Further study of these putative phenotypes may identify important differences in pathophysiology and other aetiologically important factors. 01 July 2011
  • Quality of Life Friends Couple walking in woods Parkinson's Disease and Quality of Life Balancing PerspectivesThe World Health Organization (WHO) states that globally 35 % of lost health (measured by disability-adjusted life years) is due to brain disease. Furthermore, in the near future, brain disease could overtake cardiovascular disease and cancer as the biggest burden on human health. 01 July 2011
  • Quality of Life Issues Parkinson's Disease and Quality of Life A Patient's PerspectiveQuality of life (QoL) for the person with Parkinson's disease (PD) relies heavily on the effectiveness of communication between patient and healthcare providers. It is only through a successful interaction between clinical expertise and patient experience together with lifestyle choice that the most appropriate management strategies for a person with PD can be devised and implemented. 01 July 2011
  • Medication pills chart stethoscope Parkinson's Disease and Quality of Life A Clinician's PerspectiveThe link between non-motor symptoms and reduced QoL has important implications for the management of PD because the early non-motor symptoms often appear before patients are given antiparkinsonian therapy (as motor symptoms are usually the trigger for starting therapy) and almost every patient with PD has non-motor symptoms. 01 July 2011
  • Medication pills chart stethoscope Multidisciplinary Team Work Can Improve the Care of Families With Parkinson's DiseaseThere are several approaches or models that can be used simple parallel, consultative or collaborative approaches are usually based on informal sharing of information, whereas coordinated, multidisciplinary and interdisciplinary approaches involve more formalised teams usually having regular meetings and making group decisions. 01 July 2011
  • Quality of Life Friends Couple walking in woods Innovation and Education to Improve the Management of Parkinson's DiseaseWhile management has advanced since the 1960s with the use of alternative symptomatic treatments, adjunctive agents, electric brain stimulation approaches and new methods of drug delivery, no treatment is currently known that is capable of arresting the progressive nature of the disease. 01 July 2011
Page: [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [+11]